Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValereum Plc Regulatory News (VLRM.PL)

Share Price Information for Valereum Plc (VLRM.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.27    -0.06 (-2.58%)
Bid:
2.24
Ask:
2.30
Spread: 0.06 (2.679%)
Market Cap: £12.31m
VLRM.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Valereum Plc Share Chart

OTCQB Application Submitted

5 Jun 2024 15:33

RNS Number : 2806R
Valereum PLC
05 June 2024
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")

 

05/06/2024

Valereum Plc

("Valereum" or the "Company")

 

OTCQB Application Submitted

 

Valereum Plc (AQSE: VLRM) is pleased to announce that an application has been filed with the OTC Markets Group for the Company's ordinary shares to be publicly cross traded on the OTCQB Market based in the United States, which upon approval, would make Valereum's shares more widely available to North American investors. This aligns with the Company's aims to deliver shareholder value and increase the business footprint globally.

 

The directors of the Company accept responsibility for the contents of this announcement.

 

For more information, please visit the Company's website at www.vlrm.com

 

For further information, please contact:

 

Valereum Plc

James Formolli, Chairman

Tel: +971 4584 6284

 

Stanford Capital Partners

Tel: 023 3650 3650

Bob Pountney

Patrick Claridge

 

AQSE Corporate Adviser

First Sentinel Corporate Finance

Brian Stockbridge

Tel: +44 20 3855 5551

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXEALKSEDALEFA
Date   Source Headline
31st May 20243:02 pmRNSAgreed Subscription to Raise £2 million
31st May 202410:10 amRNSPartnership with Securities & Trading Technology
31st May 202410:10 amRNSRemuneration Update - Warrant and Option Issue
12th Apr 20247:00 amRNSAppointment of Corporate Broker
11th Apr 20249:37 amRNSResult of Annual General Meeting - April 2024
28th Mar 20242:00 pmRNSAppointment of PR Agency and Interim Funding
20th Mar 202411:05 amRNSNotice of Annual General Meeting
20th Feb 20247:00 amRNSStrategy Update and the Launch of “The Bridge”
31st Jan 20247:00 amRNSCompletion of the Acquisition of GSX Group
15th Jan 20247:00 amRNSMarket Update on Mattereum
10th Jan 20247:00 amRNSBoard Appointments, Update on EGM and AGM
22nd Dec 202312:09 pmRNSAcquisition of Valereum Collections and AGM Update
18th Dec 20237:00 amRNSAcquisition of the GSX Group
30th Nov 202310:00 amRNSNew Board Appointment
28th Nov 202310:00 amRNSRemoval of CLN’s Update
27th Nov 20237:00 amRNSRestoration to Trading & Update on Acquisition
17th Nov 20237:00 amRNSValereum PLC update on the acquisition of the GSX
27th Oct 20239:05 amRNSAppointment of New Directors
26th Oct 20238:13 amRNSChange of Directors
24th Oct 20232:21 pmRNSGSX Acquisition Update and Director Resignation
3rd Oct 20237:00 amRNSInterim Results for the six months to 30 June 2023
31st Aug 20232:22 pmRNSReverse Takeover & Suspension of Trading
31st Aug 202311:22 amRNSUpdate on the acquisition of the GSX
23rd Aug 20231:36 pmRNSAppointment of Jack Sun as Finance Director
21st Jul 202310:56 amRNSUpdate on GSX Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.